California Decides Not to List BPA as a Toxic Chemical
The Natural Resources Defense Council has filed a legal petition with the California Environmental Protection Agency asking for another review of Bisphenol-A (BPA).
The Natural Resources Defense Council has filed a legal petition with the California Environmental Protection Agency asking for another review of Bisphenol-A (BPA).
Dr. Joshua Sharfstein, deputy FDA commissioner, testified before the House Rules Committee that feeding antibiotics to healthy farm animals should stop. The Union of Concerned Scientists has estimated that as much as 70% of the antibiotics used in the US are given to healthy farm animals. They are traditionally used to encourage growth or prevent […]
A newly published, randomized–controlled trial has concluded that a natural supplement, red yeast rice, had significant cholesterol-lowering properties. This is important news for those who cannot take (or would prefer not to take) statin drugs because of the medication’s side effects.
Americans are demanding to know how the US Food and Drug Administration makes its decisions about the medicine they take and the food they consume.
If you value your privacy, it’s urgent that you realize how mandatory health insurance coverage could give others full access to your medical records.
Mark Hyman, MD—author, practitioner, and educator in functional medicine—has hit the pavement in Washington, DC, to educate lawmakers and policymakers that universal healthcare coverage based on an “outdated 19th- and 20th-century model of medicine will lead us into danger.” In his Huffington Post article, “How to Fix Obama’s Health Plan Before It’s Too Late,” Dr. […]
We want to start this edition of Pulse of Health Freedom with our hearty thanks for sending Congress your messages on HR2749, the Waxman–Dingell bill (also known as the Food Safety Enhancement Act of 2009, or FSEA), which was the focus of last week’s newsletter. Thousands of messages poured in, and we are tremendously grateful […]
The June 16 edition of Pulse of Health Freedom discussed the suspension of the NIH-sponsored clinical trial for chelation therapy known as the TACT study. The study’s investigators and coordinators have now been notified to resume all TACT activities, including the chelation infusions, patient follow-up, and vitamin distribution.
The Celebrex and Vioxx debacle, the Rezulin recall, and many other problems have raised concerns about the FDA’s ability to address prescription drug safety. Whistleblowers, including FDA drug researcher David Graham, have made national headlines with Congressional testimony taking the FDA to task.
Business journals have chronicled the rise in healthcare costs for the past 30 years, and have linked them to America’s increasing inability to compete effectively in the global marketplace. The US spends more per capita than any other nation on the planet on its medical care, currently 17.5% of our GDP. According to AP articles, […]